Form 4: Inovio Pharmaceuticals Director Lota S. Zoth Reports Stock Transactions

Director Lota S. Zoth reports the vesting and disposal of restricted stock units resulting in the acquisition and disposal of common stock.

Summary

• On May 21, 2025, Lota S. Zoth, a director of Inovio Pharmaceuticals, reported transactions involving restricted stock units.
• 2,167 restricted stock units vested and were converted into common stock.
• Simultaneously, 2,167 shares of common stock were disposed of.
• Following these transactions, Zoth still beneficially owns 8,726 shares of common stock.

Sentiment

Score: 5

Explanation: This is a routine filing related to stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider trading activity.

Key Dates

Keywords

Form 4, Inovio Pharmaceuticals, Director, Stock Transaction, Beneficial Ownership, Restricted Stock Units, Common Stock, Zoth